Cognitive Training, and Aerobic Exercise Keith H. Nuechterlein, - - PowerPoint PPT Presentation

cognitive training and aerobic exercise keith h
SMART_READER_LITE
LIVE PREVIEW

Cognitive Training, and Aerobic Exercise Keith H. Nuechterlein, - - PowerPoint PPT Presentation

Successful Treatments for Early Psychosis: Consistent Antipsychotic Use, Supportive Education/Employment, Cognitive Training, and Aerobic Exercise Keith H. Nuechterlein, Ph.D. Distinguished Professor UCLA Departments of Psychiatry and


slide-1
SLIDE 1

Successful Treatments for Early Psychosis: Consistent Antipsychotic Use, Supportive Education/Employment, Cognitive Training, and Aerobic Exercise

Keith H. Nuechterlein, Ph.D. Distinguished Professor UCLA Departments of Psychiatry and Psychology, Semel Institute for Neuroscience & Human Behavior Director, UCLA Center for Neurocognition and Emotion in Schizophrenia

slide-2
SLIDE 2

Principles of Individual Placement and Support (IPS) Model (Robert Drake & Deborah Becker)

  • Work rehabilitation is integral

component of mental health treatment, not separate (job specialist w/in clinical team)

  • Goal is competitive employment in

typical work settings

  • Emphasis is on obtaining jobs directly,

rather than after lengthy pre- employment training

slide-3
SLIDE 3

Principles of Individual Placement and Support (IPS) Model (Robert Drake & Deborah Becker)

  • Continuous vocational rehabilitation

services based in real work experiences

  • Follow-along support to sustain

employment

  • Services based on consumers’

preferences and choices

  • Outreach into community
slide-4
SLIDE 4

Percentage Returning to Competitive Work

  • r Regular School (N = 69)

44 83 92 22 41 60 10 20 30 40 50 60 70 80 90 100 Baseline First 6 months 7 to 18 months Percentage of Group

IPS-WFM Separate VR

Adjusting for non-significant baseline differences, Wald x2 = 7.73, p < . 0054 for 1st 6 mos.; Wald x2 = 4.73, p < .03 for next year

slide-5
SLIDE 5

Total Number of Weeks in Competitive

Work or Regular School Over 18 Months (N = 69)

10 20 30 40 50 Treatment Group 41.8 25.9 Total Weeks at Work or School

IPS-WFM Separate VR

F = 8.43, p < .005

slide-6
SLIDE 6

Premorbid Adjustment Environmental Stress Schizophrenic Negative Symptoms Disorganized Symptoms Coping by the Patient and Significant Others

Attention and Perceptual Processing

Neurocognitive Factors

Working Memory

Verbal Memory & Processing Speed

Learning of Work Skills

Three cognitive factors account for 52% of variance in return to work or school 9 months later in recent-onset schizophrenia

Return to Work or School

Nuechterlein et al., Schiz Bull, 2011

slide-7
SLIDE 7

Medication Non-Adherence (from Peter Weiden)

  • 50% of patients have significant non-

adherence within one year of beginning treatment.

  • 75% within two years.
  • 50% of the direct medical costs of

psychiatric hospitalization attributed to non-adherence.

slide-8
SLIDE 8

UCLA Study Design

  • 12-month randomized controlled trial with first-

episode schizophrenia patients at the UCLA Aftercare Research Program

  • Patients received Individual Placement and

Support, a form of supported education and supported employment, to provide a context of active work rehabilitation

  • After stabilization, patients were randomly

assigned to the medication condition and the psychosocial treatment condition (2 X 2 design)

slide-9
SLIDE 9

UCLA First-Episode Randomized Controlled Trial

  • f LAI vs. Oral Risperidone: Time to 1st Relapse

Kaplan Meier: χ2 (1) = 9.9, p = .002

slide-10
SLIDE 10

Correlations between Antipsychotic Medication Adherence and Cognitive Gains in First-Episode Schizophrenia (n = 57 at 6 months)

0.05 0.1 0.15 0.2 0.25 0.3 0.35 Overall Composite* Working Memory* Visual Lrng* Social Cognition

Correlation

MCCB Gain in 6 Mo.

* p < .05; + p < .10

slide-11
SLIDE 11

MCCB Overall Composite Score Covarying for Medication Adherence and Finishing Full 1-Year Protocol (n = 46)

26 28 30 32 34 36 38 Baseline 12 Months T Score Cog Trng Healthy Beh Trng

Group X Time interaction, p = .025

slide-12
SLIDE 12

Global Functioning Scale: Role Effect in 12 Months (n = 53)

3 3.5 4 4.5 5 5.5 6 Baseline 12 Months Work/School Functioning Cog Trng Healthy Beh Trng

Group X Time interaction, p = .03, Cohen’s d = .62

slide-13
SLIDE 13

Pilot Study of Adding Aerobic Exercise to Cognitive Training

  • Increasing evidence that aerobic exercise

releases neurotrophic factors (e.g., brain- derived neurotrophic factor) that stimulate synaptic plasticity and enhance learning

  • We hypothesize that adding regular

aerobic exercise to neuroplasticity-based cognitive training will increase cognitive gains

slide-14
SLIDE 14

Cognitive Training & Exercise (CT&E) Might Enhance Impact on Global Cognition (MCCB Overall Composite Score) (n = 14)

25 27 29 31 33 35 37 39 Baseline 10 Weeks

MCCB Overall Composite T Score

CT&E CT

Estimated effect size, Cohen’s f = 0.48

slide-15
SLIDE 15

Cognitive Training & Exercise (CT&E) Might Enhance Impact on Social Cognition (n = 16)

30 32 34 36 38 40 42 44 Baseline 10 Weeks

MCCB Overall Composite T Score

CT&E CT

Estimated effect size, Cohen’s f = 0.65

slide-16
SLIDE 16

Overall Conclusions

  • Supported education/employment can

strikingly increase the proportion of patients who return to school or a job after an initial psychotic episode.

  • Long-acting injectable antipsychotic

medication is a promising strategy for reducing relapses and improving cognition and everyday functioning in recent-onset schizophrenia.

slide-17
SLIDE 17

Overall Conclusions

  • Systematic cognitive training can impact

cognitive functioning and everyday functioning in the early course of schizophrenia.

  • Aerobic exercise and cognitive training

might have synergistic effects on learning and overall cognitive functioning that enhance the impact of cognitive training alone.

slide-18
SLIDE 18

Investigators Keith H. Nuechterlein, Ph.D. (P.I.) Kenneth Subotnik, Ph.D. Joseph Ventura, Ph.D. George Bartzokis, M.D. Sarah McEwen, Ph.D. Denise Gretchen-Doorly, Ph.D. Treating Psychiatrists Michael Gitlin, M.D. Laurie Casaus, M.D. John Luo, M.D. Michael Boucher, M.D. Case Managers/Therapists Nicole R. DeTore, M.A. Luana Turner, Psy.D. Yurika Sturdevant, Psy.D. Statistical Consultation Gerhard S. Hellmann, Ph.D. Catherine Sugar, Ph.D. Sun Hwang, M.P.H. Research Assistants Craig Childress, M.A. Kimberle Kelly, M.A. Robin Kite, M.A. Jacqueline Hayata, B.A. Lilian Medina, B.A. Rachel Wood, M.A. Arielle Ered, B.A. Research Center Administrator Fe Asuan, B.A.

UCLA Aftercare Research Program Staff